123 related articles for article (PubMed ID: 37906137)
1. [Clinical significance of PDGFRβ gene testing in hematological tumors].
Guo M; Guo F; Zhang Y; Cheng H; Tang G; Huang Z; Gong S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Nov; 40(11):1334-1339. PubMed ID: 37906137
[TBL] [Abstract][Full Text] [Related]
2. [Clinical and laboratory study of myleodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) with PDGFRβ abnormalities].
Gong SL; Qiu HY; Song XM; Shao R; Wang JM
Zhonghua Xue Ye Xue Za Zhi; 2010 Aug; 31(8):540-4. PubMed ID: 21122334
[TBL] [Abstract][Full Text] [Related]
3. [The study of 4 cases of myeloid neoplasm with t (5;12) (q33;p13) and the literatures review].
Kou L; Pan J; Qiu H; Chen S; Cen J; Zhang J; Bai S; Wu C; Wu Y; Gong Y; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):302-7. PubMed ID: 27093993
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Significance of FGFR1 Gene Abnormalities in Blood Tumors].
Zhang CL; Tang GS; Guo MQ; Cheng H; Liu MD; Yang JM; Gong SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):983-988. PubMed ID: 32552969
[TBL] [Abstract][Full Text] [Related]
5. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG).
Jaju RJ; Haas OA; Neat M; Harbott J; Saha V; Boultwood J; Brown JM; Pirc-Danoewinata H; Krings BW; Müller U; Morris SW; Wainscoat JS; Kearney L
Blood; 1999 Jul; 94(2):773-80. PubMed ID: 10397745
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
Liu D; Zhang Y; Chen S; Pan J; He X; Liang J; Chen Z
Cancer Genet; 2015 Jun; 208(6):333-40. PubMed ID: 26032184
[TBL] [Abstract][Full Text] [Related]
7. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
Moosavi SA; Sanchez J; Adeyinka A
Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
[TBL] [Abstract][Full Text] [Related]
8. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
Sokolic RA; Ferguson W; Mark HF
Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
[TBL] [Abstract][Full Text] [Related]
9. 11q23 abnormalities in adult Chinese patients with hematological malignancies.
Zhao X; Li S; Li N; Fan R; Lin G; Wang X
Med Oncol; 2014 Aug; 31(8):115. PubMed ID: 25008067
[TBL] [Abstract][Full Text] [Related]
10. Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.
Xu W; Li JY; Liu Q; Zhu Y; Pan JL; Qiu HR; Xue YQ
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e86-95. PubMed ID: 20089000
[TBL] [Abstract][Full Text] [Related]
11. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of del(20q) in patients with hematological malignancies.
Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic evidence of Y chromosome loss in male patients with hematological disorders.
Zhang LJ; Shin ES; Yu ZX; Li SB
Chin Med J (Engl); 2007 Nov; 120(22):2002-5. PubMed ID: 18067786
[TBL] [Abstract][Full Text] [Related]
15. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
[TBL] [Abstract][Full Text] [Related]
17. Translocations between the long arms of chromosomes 1 and 5 in hematologic malignancies are strongly associated with neoplasms of the myeloid lineages.
Johansson B; Brøndum-Nielsen K; Billström R; Schiødt I; Mitelman F
Cancer Genet Cytogenet; 1997 Dec; 99(2):97-101. PubMed ID: 9398862
[TBL] [Abstract][Full Text] [Related]
18. Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.
Gong SL; Guo MQ; Tang GS; Zhang CL; Qiu HY; Hu XX; Yang JM
Oncol Lett; 2016 Jan; 11(1):770-774. PubMed ID: 26870282
[TBL] [Abstract][Full Text] [Related]
19. [Allo-HSCT for acute myeloid leukemia with myelodysplastic-related changes: a clinical analysis].
Zhang HX; Pang AM; Chen X; Zhang RL; Zhai WH; Ma QL; Yang DL; Wei JL; He Y; Feng SZ; Han MZ; Jiang EL
Zhonghua Xue Ye Xue Za Zhi; 2021 Oct; 42(10):814-822. PubMed ID: 34788920
[No Abstract] [Full Text] [Related]
20. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
